Literature DB >> 19737935

Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity.

So Young Bu1, Mara T Mashek, Douglas G Mashek.   

Abstract

Long chain acyl-CoA synthetases (ACSL) and fatty acid transport proteins (FATP) activate fatty acids to acyl-CoAs in the initial step of fatty acid metabolism. Numerous isoforms of ACSL and FATP exist with different tissue distribution patterns, intracellular locations, and substrate preferences, suggesting that each isoform has distinct functions in channeling fatty acids into different metabolic pathways. Because fatty acids, acyl-CoAs, and downstream lipid metabolites regulate various transcription factors that control hepatic energy metabolism, we hypothesized that ACSL or FATP isoforms differentially regulate hepatic gene expression. Using small interference RNA (siRNA), we knocked down each liver-specific ACSL and FATP isoform in rat primary hepatocyte cultures and subsequently analyzed reporter gene activity of numerous transcription factors and performed quantitative mRNA analysis of their target genes. Compared with control cells, which were transfected with control siRNA, knockdown of acyl-CoA synthetase 3 (ACSL3) significantly decreased reporter gene activity of several lipogenic transcription factors such as peroxisome proliferator activation receptor-gamma, carbohydrate-responsive element-binding protein, sterol regulatory element-binding protein-1c, and liver X receptor-alpha and the expression of their target genes. These findings were further supported by metabolic labeling studies that showed [1-(14)C]acetate incorporation into lipid extracts was decreased in cells treated with ACSL3 siRNAs and that ACSL3 expression is up-regulated in ob/ob mice and mice fed a high sucrose diet. ACSL3 knockdown decreased total acyl-CoA synthetase activity without substantially altering the expression of other ACSL isoforms. In summary, these results identify a novel role for ACSL3 in mediating transcriptional control of hepatic lipogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737935      PMCID: PMC2781602          DOI: 10.1074/jbc.M109.036665

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Acyl-CoAs are functionally channeled in liver: potential role of acyl-CoA synthetase.

Authors:  D M Muoio; T M Lewin; P Wiedmer; R A Coleman
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-12       Impact factor: 4.310

2.  Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.

Authors:  J J Repa; G Liang; J Ou; Y Bashmakov; J M Lobaccaro; I Shimomura; B Shan; M S Brown; J L Goldstein; D J Mangelsdorf
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

3.  Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6.

Authors:  Cynthia G Van Horn; Jorge M Caviglia; Lei O Li; Shuli Wang; Deborah A Granger; Rosalind A Coleman
Journal:  Biochemistry       Date:  2005-02-08       Impact factor: 3.162

4.  Long-chain acyl-CoA synthetases and fatty acid channeling.

Authors:  Douglas G Mashek; Lei O Li; Rosalind A Coleman
Journal:  Future Lipidol       Date:  2007-08

5.  Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes.

Authors:  Lei O Li; Douglas G Mashek; Jie An; Scott D Doughman; Christopher B Newgard; Rosalind A Coleman
Journal:  J Biol Chem       Date:  2006-10-06       Impact factor: 5.157

6.  Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver.

Authors:  K Tobe; R Suzuki; M Aoyama; T Yamauchi; J Kamon; N Kubota; Y Terauchi; J Matsui; Y Akanuma; S Kimura; J Tanaka; M Abe; J Ohsumi; R Nagai; T Kadowaki
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

7.  PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.

Authors:  Susan E Schadinger; Nancy L R Bucher; Barbara M Schreiber; Stephen R Farmer
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-01-11       Impact factor: 4.310

Review 8.  Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription.

Authors:  Friedhelm Schroeder; Anca D Petrescu; Huan Huang; Barbara P Atshaves; Avery L McIntosh; Gregory G Martin; Heather A Hostetler; Aude Vespa; Danilo Landrock; Kerstin K Landrock; H Ross Payne; Ann B Kier
Journal:  Lipids       Date:  2007-09-19       Impact factor: 1.880

9.  Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation.

Authors:  Cassandra E Forsythe; Stephen D Phinney; Maria Luz Fernandez; Erin E Quann; Richard J Wood; Doug M Bibus; William J Kraemer; Richard D Feinman; Jeff S Volek
Journal:  Lipids       Date:  2007-11-29       Impact factor: 1.880

10.  Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity.

Authors:  Jessica M Sapiro; Mara T Mashek; Andrew S Greenberg; Douglas G Mashek
Journal:  J Lipid Res       Date:  2009-03-21       Impact factor: 5.922

View more
  47 in total

1.  Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity.

Authors:  Yuli Cai; Honggui Li; Mengyang Liu; Ya Pei; Juan Zheng; Jing Zhou; Xianjun Luo; Wenya Huang; Linqiang Ma; Qiuhua Yang; Shaodong Guo; Xiaoqiu Xiao; Qifu Li; Tianshu Zeng; Fanyin Meng; Heather Francis; Shannon Glaser; Lulu Chen; Yuqing Huo; Gianfranco Alpini; Chaodong Wu
Journal:  Hepatology       Date:  2018-05-10       Impact factor: 17.425

Review 2.  Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update.

Authors:  Sheng Yan; Xue-Feng Yang; Hao-Lei Liu; Nian Fu; Yan Ouyang; Kai Qing
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

3.  Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth.

Authors:  D Obinata; K Takayama; K Fujiwara; T Suzuki; S Tsutsumi; N Fukuda; H Nagase; T Fujimura; T Urano; Y Homma; H Aburatani; S Takahashi; S Inoue
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

4.  Integrated Regulation of Hepatic Lipid and Glucose Metabolism by Adipose Triacylglycerol Lipase and FoxO Proteins.

Authors:  Wenwei Zhang; So Young Bu; Mara T Mashek; InSug O-Sullivan; Zakaria Sibai; Salmaan A Khan; Olga Ilkayeva; Christopher B Newgard; Douglas G Mashek; Terry G Unterman
Journal:  Cell Rep       Date:  2016-03-31       Impact factor: 9.423

5.  CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.

Authors:  Heather J Wright; Jue Hou; Binzhi Xu; Marvin Cortez; Eric O Potma; Bruce J Tromberg; Olga V Razorenova
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

6.  High-fructose diet downregulates long-chain acyl-CoA synthetase 3 expression in liver of hamsters via impairing LXR/RXR signaling pathway.

Authors:  Bin Dong; Chin Fung Kelvin Kan; Amar B Singh; Jingwen Liu
Journal:  J Lipid Res       Date:  2013-02-20       Impact factor: 5.922

7.  Molecular cloning of the goose ACSL3 and ACSL5 coding domain sequences and their expression characteristics during goose fatty liver development.

Authors:  H He; H H Liu; J W Wang; J Lv; L Li; Z X Pan
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

Review 8.  Acyl-CoA metabolism and partitioning.

Authors:  Trisha J Grevengoed; Eric L Klett; Rosalind A Coleman
Journal:  Annu Rev Nutr       Date:  2014-04-10       Impact factor: 11.848

9.  Maternal high-fat diet during pregnancy and lactation affects hepatic lipid metabolism in early life of offspring rat.

Authors:  Yanhong Huang; Tingting Ye; Chongxiao Liu; Fang Fang; Yuanwen Chen; Yan Dong
Journal:  J Biosci       Date:  2017-06       Impact factor: 1.826

10.  PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease.

Authors:  James P Hardwick; Douglas Osei-Hyiaman; Homer Wiland; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  PPAR Res       Date:  2010-03-16       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.